At a glance
- Originator Pfizer
- Class Antibacterials; Cephalosporins
- Mechanism of Action Cell wall inhibitors; DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 04 Aug 1998 No-Development-Reported for Bacterial infections in USA (Unknown route)
- 02 Feb 1996 Preclinical development for Bacterial infections in USA (Unknown route)